| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1031640382 |
| P356 | DOI | 10.1007/BF01629576 |
| P698 | PubMed publication ID | 9116389 |
| P2093 | author name string | J Farley | |
| D J Baylink | |||
| A Tabuenca | |||
| M M Fischer | |||
| J R Talbot | |||
| C Libanati | |||
| S M Farley | |||
| P2860 | cites work | Bone-alkaline phosphatase as indicator of bone formation | Q28325560 |
| Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis | Q34374271 | ||
| Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion | Q34569315 | ||
| A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis | Q34695251 | ||
| The effect of fluoride and calcium on spinal bone mineral content: a controlled, prospective (3 years) study | Q36432059 | ||
| Bone remodeling and calcium metabolism: A correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's disease | Q41252556 | ||
| Efficacy of long-term fluoride and calcium therapy in correcting the deficit of spinal bone density in osteoporosis | Q44380426 | ||
| Spinal fractures during fluoride therapy for osteoporosis: relationship to spinal bone density | Q46049642 | ||
| Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease. | Q52296809 | ||
| Relationship between trabecular vertebral body density and fractures: a quantitative definition of spinal osteoporosis. | Q54423254 | ||
| Restoring and maintaining bone in osteopenic female rat skeleton: I. Changes in bone mass and structure | Q67566427 | ||
| Production of new trabecular bone in osteopenic ovariectomized rats by prostaglandin E2 | Q67753629 | ||
| Partial loss of anabolic effect of prostaglandin E2 on bone after its withdrawal in rats | Q67999547 | ||
| Loss of the anabolic effect of parathyroid hormone on bone after discontinuation of hormone in rats | Q69447189 | ||
| Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures | Q69934630 | ||
| Skeletal alkaline phosphatase activity as a bone formation index in vitro | Q70140800 | ||
| Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis | Q70402110 | ||
| Treatment of osteoporosis with fluoride, calcium, and vitamin D | Q70953903 | ||
| Treatment of primary osteoporosis with fluoride and calcium. Clinical tolerance and fracture occurrence | Q71130026 | ||
| Precise measurement of vertebral mineral content using computed tomography | Q71242616 | ||
| Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observations and additional analysis | Q72323079 | ||
| P433 | issue | 6 | |
| P921 | main subject | fluoride therapy | Q5462842 |
| P304 | page(s) | 442-447 | |
| P577 | publication date | 1996-01-01 | |
| P1433 | published in | Osteoporosis International | Q7107640 |
| P1476 | title | The increase in spinal bone density that occurs in response to fluoride therapy for osteoporosis is not maintained after the therapy is discontinued | |
| P478 | volume | 6 |
| Q77734384 | Assessment of maintenance therapy with reduced doses of PTH(1-34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat |
| Q73107076 | Position of the American Dietetic Association: the impact of fluoride on health |
| Q73515338 | Position of the American Dietetic Association: the impact of fluoride on health |
| Q40850937 | The role of fluoride in the prevention of osteoporosis |
Search more.